
GSK vs IBO
$GSK vs $IBO head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
GSK vs IBO: trend, levels and the market
One year to 2026-11-17, against the S&P 500 (+9.5%). Split-adjusted daily closes.
- ·GSK is the weaker of the two on trend, below both its 50- and 200-day averages, while IBO has held above one of them.
- ·Only IBO beat the market over the past year, by 4.2%, while GSK trailed the S&P 500 at +9.5% by 4.7%.
- ·IBO has support 5.5% below at $5.83; GSK has no tested support within 35% under its price.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
GSK vs IBO: the quick read
- ·GSK is the larger company by market cap ($95.73B vs $53M).
- ·GSK has been more active on our scanner (78 vs 3 alerts in 30 days).
- ·IBO has the smaller float (8.6M vs 2.00B), which tends to mean sharper, more volatile moves.
- ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
- ·IBO trades at a small fraction of the other's share price, so position sizing and the size of a "normal" move differ a lot between them.
- ·GSK draws far more of our scanner's attention, 78 unusual-volume alerts in 30 days against 3, so it is the more actively traded of the two by some distance.
- ·They are not really peers by size: GSK is more than 1796x the market cap of IBO, so the same dollar of news moves IBO far harder.
- ·They have diverged badly over the year: IBO is near the top of its 52-week range while GSK is near the bottom of its own.
- ·GSK pays a dividend and IBO does not, which usually means one is being held for income and the other for the move.
- ·They are pulling apart today: IBO is outperforming the other by roughly 25.4 percentage points on the session.
Objective differences only. Not investment advice.
Watching GSK or IBO? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing GSK and IBO on TheDesperateTrader.
- Is GSK or IBO the better stock?
- "Better" depends on your goal, and these two are not alike. GSK is the larger company by market cap ($95.73B vs $53M). GSK has been more active on our scanner (78 vs 3 alerts in 30 days). IBO has the smaller float (8.6M vs 2.00B), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between GSK and IBO?
- The differences that matter: GSK is roughly 1796x the size of the other by market cap ($95.73B vs $53M); they trade at very different share prices ($47.96 vs $6.17); GSK sits at 14% of its 52-week range against 86% for IBO; only GSK pays a dividend; our scanner flagged GSK 78 times in the last 30 days against 3 for IBO. Everything above is measured from the latest completed session and SEC filings.
- Which of GSK and IBO is more active right now?
- Neither is showing unusual volume on the latest session, so nothing here is being driven by a volume spike. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is GSK or IBO in the stronger trend?
- GSK is below its 50-day average of $49.32 and below its 200-day average of $52.38; IBO is above its 50-day average of $4.83 and below its 200-day average of $6.18. IBO leads 5 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading GSK or IBO? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysExplore the market
Free, live market tools. No account required to look.